BPCA |
Best Pharmaceuticals for Children Act |
CDER |
Center for Drug Evaluation and Research |
CHMP |
Committee for Human Medicinal Products |
EMA |
European Medicines Agency |
FDA |
Food and Drug Administration |
FDASIA |
FDA Safety and Innovation Act |
iPSP |
initial Pediatric Study Plan |
PDCO |
Paediatric Committee |
PeRC |
Pediatric Review Committee |
PIP |
Paediatric investigation plan |
PMDA |
Pharmaceuticals and Medical Devices Agency |
PPSR |
Proposed Pediatric Study Request |
PREA |
Pharmaceutical Research Equity Act |
PRIME |
Priority medicines |
PSP |
Pediatric study plan |
SAWP |
Scientific Advice Working Party |
TGA |
Therapeutic Goods Administration |
T2DM |
Type 2 diabetes mellitus |